This inventor holds 1 USPTO granted patent. Top assignee: The Royal Institution for the Advancement of LEARNING/MCGILL University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Arghya Paul: Innovator in Therapeutic Viral Microparticles
Introduction
Arghya Paul is a notable inventor based in Longueuil, Canada. He has made significant contributions to the field of biomedical engineering, particularly in the development of therapeutic viral microparticles. His work aims to enhance stent biocompatibility and promote wound healing in vertebrate individuals.
Latest Patents
Arghya Paul holds a patent titled "Therapeutic Viral Microparticles for Promoting Stent Biofunctionality and Wound Healing in Vertebrate Individuals." This innovative approach utilizes viral microparticles to improve medical outcomes in patients requiring stents.
Career Highlights
Arghya is affiliated with McGill University, specifically within The Royal Institution for the Advancement of Learning. His research focuses on the intersection of virology and medical device technology, showcasing his commitment to advancing healthcare solutions.
Collaborations
He has collaborated with esteemed colleagues such as Satya Prakash and Dominique Shum-Tim, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Arghya Paul's work exemplifies the impact of innovative thinking in the medical field. His contributions to therapeutic viral microparticles are paving the way for improved healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile